| P50 | author | Taosheng Huang | Q74605870 |
| | Dmitry Tchapyjnikov | Q80767981 |
| P2093 | author name string | Marie T McDonald | |
| | Laura G Reinholdt | |
| | Yanyan Peng | |
| | Allyn McConkie-Rosell | |
| | Elizabeth A Sellars | |
| | Jesse Slone | |
| | Adam Chamberlin | |
| | Belinda Harris | |
| | Julie Kaylor | |
| | Monica Lemmon | |
| | Laura A Gonzalez-Krellwitz | |
| | Mays Antonine El-Dairi | |
| P2860 | cites work | Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen----q25 are expressed in steroidogenic tissues | Q24293030 |
| | The 20 years of PROSITE | Q24650692 |
| | Functional reconstitution of mitochondrial Fe/S cluster synthesis on Isu1 reveals the involvement of ferredoxin | Q27695962 |
| | Mutations in SPATA5 Are Associated with Microcephaly, Intellectual Disability, Seizures, and Hearing Loss | Q28118528 |
| | Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia | Q28250989 |
| | Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability | Q28255405 |
| | Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis | Q28256698 |
| | Mitochondrial cytochrome P-450scc. Mechanism of electron transport by adrenodoxin | Q28273290 |
| | Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion | Q28275699 |
| | Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells | Q28361124 |
| | Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia | Q28646412 |
| | A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine | Q29547303 |
| | Cerebellar pathology in Friedreich's ataxia: atrophied dentate nuclei with normal iron content. | Q30426640 |
| | Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene | Q31561021 |
| | Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease. | Q33684033 |
| | Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. | Q33701891 |
| | Targeting chelatable iron as a therapeutic modality in Parkinson's disease | Q33768106 |
| | Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis | Q33977876 |
| | Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation | Q34152888 |
| | A pilot trial of deferiprone for neurodegeneration with brain iron accumulation | Q35528710 |
| | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders | Q35793513 |
| | Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis | Q36538094 |
| | Mutations in LYRM4, encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes | Q37463296 |
| | Human Mitochondrial Ferredoxin 1 (FDX1) and Ferredoxin 2 (FDX2) Both Bind Cysteine Desulfurase and Donate Electrons for Iron-Sulfur Cluster Biosynthesis. | Q37607678 |
| | Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation | Q38075335 |
| | Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. | Q38219400 |
| | The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency | Q43129154 |
| | Individual dopaminergic neurons show raised iron levels in Parkinson disease. | Q45305197 |
| | Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy | Q46282814 |
| | Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice. | Q47249910 |
| | FDXR Mutations Cause Sensorial Neuropathies and Expand the Spectrum of Mitochondrial Fe-S-Synthesis Diseases | Q47719193 |
| | Clinical Experience With Deferiprone Treatment for Friedreich Ataxia | Q47786184 |
| | A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies | Q48836050 |
| | Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. | Q53085750 |
| P433 | issue | 12 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 1211-1222 | |
| P577 | publication date | 2018-09-25 | |
| P1433 | published in | Journal of Human Genetics | Q6295302 |
| P1476 | title | Biallelic mutations in FDXR cause neurodegeneration associated with inflammation | |
| P478 | volume | 63 | |